Antony C. Mattessich Ocular Therapeutix, Inc (OCUL) insider trading activity

Antony C. Mattessich is President and CEO of OCULAR THERAPEUTIX, INC. Currently has a direct ownership of 588,701 shares of OCUL, which is worth approximately $6.12 Million. The most recent transaction as insider was on Feb 05, 2024, when has been sold 19,642 shares (Common Stock) at a price of $4.86 per share, resulting in proceeds of $95,460. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 589K

0% 3M change

31.91% 12M change

Total Value Held $6.12 Million

Antony C. Mattessich Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 05 2024	BUY Open market or private sale	$95,460 $4.86 p/Share	19,642 Added 3.23%	588,701 Common Stock
Feb 03 2024	BUY Grant, award, or other acquisition	-	180,400 Added 22.87%	608,343 Common Stock
Jan 31 2024	SELL Open market or private sale	$90,773 $4.95 p/Share	18,338 Reduced 4.11%	427,943 Common Stock
Feb 06 2023	SELL Open market or private sale	$83,396 $4.24 p/Share	19,669 Reduced 4.22%	446,281 Common Stock
Jan 30 2023	BUY Grant, award, or other acquisition	-	176,300 Added 27.45%	465,950 Common Stock
Feb 03 2022	BUY Grant, award, or other acquisition	-	186,750 Added 39.2%	289,650 Common Stock
Aug 20 2021	BUY Open market or private purchase	$49,450 $9.89 p/Share	5,000 Added 4.63%	102,900 Common Stock

Also insider at

AURA

Aura Biosciences, Inc. Healthcare

ACM